.. Thérapeutique-médicamenteuse, Etude comparative portant sur l'efficacité et la tolérance des différents traitements utilisés dans les spasmes infantiles : cas de l'étude, p.51

J. Audhoui, G. Chamba, J. P. Dupeyron, T. Dupin-spriet, J. M. Gazengel et al., Les nausées et vomissements chimioinduits, Cah. Form. Monit. Pharm. Lab. II, 2005.

J. J. Baker, J. L. Lokey, N. A. Price, S. H. Winokur, J. Bowen et al., Nabilone as an antiemetic, N. Engl. J. Med, vol.728, issue.13, p.301, 1979.

T. Baram, Pathophysiology of massive infantile spasms: Perpective on the putative role of the brain adrenal axis, Annals of Neurology, vol.79, issue.suppl, pp.231-236, 1993.
DOI : 10.1016/S0387-7604(12)80125-2

T. Baram, Models for infantile spasms: An arduous journey to the holy grail???, Annals of Neurology, vol.26, issue.2
DOI : 10.1212/WNL.42.6.1171

M. Barann, M. Göthert, M. Brüss, and H. Bönisch, Inhibition by steroids of [14C]-guanidinium flux through the voltage-gated sodium channel and the cation channel of the 5-HT3 receptor of N1E-115 neuroblastoma cells, Naunyn-Schmiedeberg's Archives of Pharmacology, vol.360, issue.3, pp.234-241, 1999.
DOI : 10.1007/s002109900089

. Antiemetics, American Society of Clinical Oncology Clinical Practice Guideline Update, J. Oncol. Pract, vol.7, issue.6, pp.395-398, 2011.

B. Youssef, S. Belguith, J. Hadiji, and R. , Les corticoïdes en médecine vétérinaire Ecole de médecine vétérinaire Sidi Thabet Disponible sur http, 2015.

C. Bredin, M. Massoure, D. Corberand, and P. Rey, Complications digestives des chimiothérapies. EMC -Gastro-Entérologie, pp.1-15, 2010.
DOI : 10.1016/s1155-1968(10)19795-8

K. L. Brunson, S. Avishai-eliner, and T. Baram, Acth treatment of infantile spasms: Mechanisms of its effects in modulation of neuronal excitability, In International Review, pp.185-197, 2002.
DOI : 10.1016/S0074-7742(02)49013-7

F. Chast, Histoire de la corticothérapie. Rev. Médecine Interne, pp.258-263, 2013.

P. Chellamuthu, S. Sharma, P. Jain, J. S. Kaushik, A. Seth et al., High dose (4 mg/kg/day) versus usual dose (2 mg/kg/day) oral prednisolone for treatment of infantile spasms: An open-label, randomized controlled trial, Epilepsy Res, vol.2014, issue.1089, pp.1378-1384

C. Chu, C. Hsing, J. Shieh, C. Chien, C. Ho et al., The cellular mechanisms of the antiemetic action of dexamethasone and related glucocorticoids against vomiting, European Journal of Pharmacology, vol.722, pp.2014-722
DOI : 10.1016/j.ejphar.2013.10.008

L. Chudomelova, M. H. Scantlebury, E. Raffo, A. Coppola, D. Betancourth et al., Modeling new therapies for infantile spasms, Epilepsia, vol.51, issue.suppl 13, p.51, 2010.
DOI : 10.1212/01.WNL.0000127773.72699.C8

S. Couraud, A. C. Toffart, L. Sakhri, and B. Etienne-mastroianni, Soins de support et nutrition 4ème édition Disponible sur http, p.5, 2015.

C. Dejean and D. Richard, Mécanismes d'action des glucocorticoïdes. Rev. Médecine Interne, pp.264-268, 2013.

I. Dolizy, E. Jonveaux, C. Jouannaud, L. Lancry, J. B. Rey et al., Prise en charge des nausées-vomissements chimio-induits. Référentiels interrégionaux en soins oncologiques de support. 2012. Disponible sur : http://www, 2015.

O. Dulac, M. Chipaux, and P. Evrard, Le syndrome de West, p.3, 2008.

J. P. Durand, I. Madelaine, and F. Scotté, Recommandations pour la prévention et le traitement des nausées et vomissements induits par la chimiothérapie, Bull. Cancer, issue.10, pp.96-951, 2009.

G. A. Estocq, Nausées -Vomissements Recommandations. Onco 92 Disponible sur, 2006.

F. Z. Fadil and M. Itri, Syndrome de West: à propos de 77 cas, Rev. Marocaine Mal. Enfant, pp.2013-2044

L. Fardet, Cortisone-info Le site d'information sur la cortisone et la corticothérapie

S. Faure, Les traitements adjuvants à la chimiothérapie anticancéreuse. Actualités pharmaceutiques, pp.10-20, 2008.
DOI : 10.1016/s0515-3700(08)70303-3

S. Faure, Anti-inflammatoires stéroïdiens. Actualités pharmaceutiques, pp.51-56, 2009.

A. A. Fauser, G. Pizzocaro, J. Schueller, D. Khayat, and P. Wilkinson, A double-blind, randomised, parallel study comparing intravenous dolasetron plus dexamethasone and intravenous dolasetron alone for the management of fractionated cisplatinrelated nausea and vomiting, Support. Care Cancer, vol.8, issue.1, pp.49-54, 2000.

M. Fredrikson, T. J. Hursti, G. Steineck, C. J. Fürst, S. Börjesson et al., Delayed chemotherapy-induced nausea is augmented by high levels of endogenous noradrenaline, British Journal of Cancer, vol.70, issue.4, pp.642-645, 1994.
DOI : 10.1038/bjc.1994.364

V. Gebbia, A. Testa, R. Valenza, G. Cannata, M. L. Tirrito et al., Oral granisetron with or without methylprednisolone versus metoclopramide plus methylprednisolone in the management of delayed nausea and vomiting induced by cisplatin-based chemotherapy. A prospective randomized trial, Cancer, vol.14, issue.10, pp.761821-1828, 1995.
DOI : 10.1090/S0002-9939-1962-0147901-6

E. Gez, A. Sulkes, L. Ochayon, C. Gera, S. Nathan et al., Methylprednisolone versus Metoclopramide as Antiemetic Treatment in Patients Receiving Adjuvant Cyclophosphamide, Methotrexate, 5-Fluorouracil (CMF) Chemotherapy: A randomized crossover blind study., Journal of Chemotherapy, vol.1, issue.6, pp.365-368, 1989.
DOI : 10.1097/00000421-198706000-00021

V. Girod and L. Grelot, Physiopathologie des vomissements en chimiothérapie oncologique, Hépato-Gastro Oncol. Dig, vol.8, issue.4, pp.279-286, 2001.

T. Glauser, Infantile Spasm (West Syndrome) Medscape. 2014 Disponible sur : http://emedicine.medscape.com/article/1176431-overview, p.5, 2015.

C. Y. Go, M. T. Mackay, S. K. Weiss, D. Stephens, T. Adams-webber et al., Evidence-based guideline update: Medical treatment of infantile spasms: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society, Neurology, vol.78, issue.24, pp.781974-1980, 2012.
DOI : 10.1212/WNL.0b013e318259e2cf

P. Goulard, Traitement des nausées et vomissements lors de chimiothérapies anticancéreuses Association Francophone des Pharmaciens Hospitaliers de Belgique Disponible sur : http://www.afphb.be/doc/afphb, 2008.

L. Grangeasse, S. Limat, and M. Woronoff-lemsi, Les anti-inflammatoires stéroïdiens ou glucocorticoïdes. Soins, pp.52-59, 2008.

S. M. Grunberg, Antiemetic activity of corticosteroids in patients receiving cancer chemotherapy: dosing, efficacy, and tolerability analysis, Annals of Oncology, vol.18, issue.2, pp.233-240, 2007.
DOI : 10.1093/annonc/mdl347

J. Guérit and D. Debatisse, Bases neurophysiologiques et principes d???interpr??tation de l?????lectroenc??phalogramme en r??animation, R??animation, vol.16, issue.6, pp.546-552, 2007.
DOI : 10.1016/j.reaurg.2007.09.012

P. Guilpain and C. Le-jeunne, Effets anti-inflammatoires et immunosuppresseurs des glucocortico??des, Presse Médicale. 2012, pp.378-383
DOI : 10.1016/j.lpm.2012.01.010

R. Gupta and R. Appleton, Corticosteroids in the management of the paediatric epilepsies, Archives of Disease in Childhood, vol.90, issue.4, pp.379-384, 2005.
DOI : 10.1136/adc.2004.051375

E. C. Hancock, J. P. Osborne, and S. W. Edwards, Treatment of infantile spasms The Cochrane Collaboration, In Cochrane Database of Systematic Reviews, vol.69, 2013.

J. Herrstedt, M. S. Aapro, J. F. Smyth, D. Favero, and A. , Corticosteroids, dopamine antagonists and other drugs, Supportive Care in Cancer, vol.6, issue.3, pp.204-214, 1998.
DOI : 10.1007/s005200050155

Y. Hirano, H. Oguni, M. Shiota, A. Nishikawa, and M. Osawa, Ketogenic diet therapy can improve ACTH-resistant West syndrome in Japan, Brain and Development, vol.37, issue.1, pp.18-22
DOI : 10.1016/j.braindev.2014.01.015

C. Ho, S. Ho, J. Wang, S. Tsai, and C. Chai, Dexamethasone Has a Central Antiemetic Mechanism in Decerebrated Cats, Anesthesia & Analgesia, vol.99, issue.3, pp.99-734, 2004.
DOI : 10.1213/01.ANE.0000130003.68288.C7

E. M. Ibrahim, H. Y. Al-idrissi, A. Ibrahim, G. Absood, E. Al-dossary et al., Antiemetic efficacy of high-dose dexamethasone: randomized, double-blind, crossover study with high-dose metoclopramide in patients receiving cancer chemotherapy, European Journal of Cancer and Clinical Oncology, vol.22, issue.3, pp.283-288, 1986.
DOI : 10.1016/0277-5379(86)90392-5

J. P. Ioannidis, P. J. Hesketh, and J. Lau, Contribution of Dexamethasone to Control of Chemotherapy-Induced Nausea and Vomiting: A Meta-Analysis of Randomized Evidence, Journal of Clinical Oncology, vol.18, issue.19, pp.18-3409, 2000.
DOI : 10.1200/JCO.2000.18.19.3409

M. Ito, T. Kumagai, Y. Yamazaki, K. Sekijima, K. Sakakibara et al., Long-term prognosis of patients with West syndrome in Japan: medical aspects, Brain and Development, vol.23, issue.7, pp.692-694, 2001.
DOI : 10.1016/S0387-7604(01)00315-1

M. Jacqueline, T. Mignot, and P. Manivet, Collection Pharma mémo, Tome Exercices, vol.268, p.2012

D. Jacquemin and D. Broucker, Manuel de soins palliatifs -4e édition: Clinique, psychologie, éthique (ed Dunod, Paris), p.303, 2014.

H. Jaseja, A plausible explanation for superiority of adreno-cortico-trophic hormone (ACTH) over oral corticosteroids in management of infantile spasms (West syndrome), Medical Hypotheses, vol.67, issue.4, pp.721-724, 2006.
DOI : 10.1016/j.mehy.2006.04.039

H. Jaseja, Justification of vigabatrin administration in West syndrome patients? Warranting a re-consideration for improvement in their quality of life, Clinical Neurology and Neurosurgery, vol.111, issue.2, pp.111-114, 2009.
DOI : 10.1016/j.clineuro.2008.08.004

H. Jaseja and B. Jaseja, Adrenocorticotrophic hormone (ACTH) therapy in infantile spasms (IS): Current evidence for its superior therapeutic efficacy, Clinical Neurology and Neurosurgery, vol.115, issue.9, pp.1919-1920, 2013.
DOI : 10.1016/j.clineuro.2013.03.011

A. L. Jones, A. S. Hill, D. Cunningham, M. Soukop, A. W. Hutcheon et al., Comparison of dexamethasone and ondansetron in the prophylaxis of emesis induced by moderately emetogenic chemotherapy. The Lancet, pp.338-483, 1991.

K. Jones, C. Go, J. Boyd, A. Ochi, B. Mccoy et al., Vigabatrin as first line treatment for infantile spasms

N. Jorand, L'analyse fonctionnelle et la structuration du milieu auprès d'un enfant atteint d'un syndrome de West

K. Jordan, C. Kasper, and H. Schmoll, Chemotherapy-induced nausea and vomiting: current and new standards in the antiemetic prophylaxis and treatment, European Journal of Cancer, vol.41, issue.2, pp.199-205, 2005.
DOI : 10.1016/j.ejca.2004.09.026

K. Jordan, F. Jahn, and M. Aapro, Recent developments in the prevention of chemotherapy-induced nausea and vomiting (CINV): a comprehensive review, Annals of Oncology, vol.6, issue.8, 2015.
DOI : 10.1016/S1470-2045(05)70284-9

A. L. Lux, S. W. Edwards, E. Hancock, A. L. Johnson, C. R. Kennedy et al., The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial, The Lancet, vol.364, issue.9447, pp.364-1773, 2004.
DOI : 10.1016/S0140-6736(04)17400-X

N. Maggio and M. Segal, Stress and corticosteroid modulation of seizures and synaptic inhibition in the hippocampus, Experimental Neurology, vol.234, issue.1, pp.200-207
DOI : 10.1016/j.expneurol.2011.12.035

A. Mailliez and J. Bonneterre, Nausées et vomissements chimio-induits : physiopathologie, prophylaxie et recommandations, Bull. Cancer, vol.97, issue.2, pp.233-243, 2010.

T. Mendonca and R. Joseph, A Case Study on West Syndrome, Paripex - Indian Journal Of Research, vol.3, issue.4, pp.204-205
DOI : 10.15373/22501991/APR2014/65

M. Milh and N. Villeneuve, Épilepsies graves de l'enfant : diagnostic électroclinique et étiologique, principes de prise en charge. EMC -Pédiatrie -Mal, pp.1-11
DOI : 10.1016/s1637-5017(12)55787-x

M. Minami, T. Endo, H. Yokota, T. Ogawa, M. Nemoto et al., Effects of CP-99, 994, a tachykinin NK1 receptor antagonist, on abdominal afferent vagal activity in ferrets: evidence for involvement of NK1 and 5-HT3 receptors, European Journal of Pharmacology, vol.428, issue.2, pp.215-220, 2001.
DOI : 10.1016/S0014-2999(01)01297-3

M. Minami, T. Endo, M. Hirafuji, N. Hamaue, Y. Liu et al., Pharmacological aspects of anticancer drug-induced emesis with emphasis on serotonin release and vagal nerve activity, Pharmacology & Therapeutics, vol.99, issue.2, pp.99-149, 2003.
DOI : 10.1016/S0163-7258(03)00057-3

L. Monassier, Les anti-inflammatoires stéroïdiens Module de Pharmacologie générale DCEM 1. Faculté de Médecine de Strasbourg Disponible sur : http://udsmed.ustrasbg .fr/pharmaco, p.8, 2005.

A. More, D. Colin, and W. Whitehouse, Infantile Spasms and West Syndrome Guideline. Children's epilepsy workstream in trent, Disponible sur, pp.8-15, 2011.

G. R. Morrow, J. T. Hickok, P. L. Andrews, and R. M. Stern, Reduction in serum cortisol after platinum based chemotherapy for cancer: A role for the HPA axis in treatment-related nausea?, Psychophysiology, vol.39, issue.4, pp.491-495, 2002.
DOI : 10.1111/1469-8986.3940491

K. Münstedt, D. Borces, M. K. Bohlmann, M. Zygmunt, and R. Von-georgi, Glucocorticoid administration in antiemetic therapy. Cancer, pp.1696-1702, 2004.

D. Muster, Médicaments de l'inflammation. EMC -Stomatologie, pp.21-29, 2005.

S. Najari, Le syndrome de West (A propos de 72 cas)

F. Netzer, Anti-Inflammatoires Stéroïdiens -Conférence Internat, 2010.

A. Nguyen-khoa, La corticosurrénale-Conférence Internat, 2010.

. Omédit, Observatoire régional des Médicaments, des Dispositifs médicaux et des Innovations Thérapeutiques) Thérapeutiques antiémétiques chez l'adulte associées à la chimiothérapie anticancéreuse. Commission anti-cancer Région Centre, 2014.

G. Orliaguet, O. Gall, and F. Benabess-lambert, Nouveautés concernant les antiinflammatoires stéroïdiens et non stéroïdiens Le praicien en anesthésie réanimation, pp.228-237, 2013.

C. Patil, S. Jadhav, S. Doifode, and M. Baig, Neuroactive steroids and their role in epilepsy, International Journal of Basic & Clinical Pharmacology, vol.1, issue.3, pp.150-159
DOI : 10.5455/2319-2003.ijbcp004212

P. Pavone, R. Falsaperla, M. Ruggieri, A. D. Praticò, and L. Pavone, West Syndrome Treatment: New Roads for an Old Syndrome, Frontiers in Neurology, vol.4, issue.4, pp.1-2, 2013.
DOI : 10.3389/fneur.2013.00113

P. Pavone, P. Striano, R. Falsaperla, L. Pavone, and M. Ruggieri, Infantile spasms syndrome, West syndrome and related phenotypes: What we know in 2013, Brain and Development, vol.36, issue.9, pp.739-751
DOI : 10.1016/j.braindev.2013.10.008

F. Peyrade, Gestion ambulatoire des nausées et vomissements chimio-induits Centre Antoine Lacassagne, INRIA Sophia Antipolis Disponible sur : http://wwwsop.inria.fr/epidaure, p.3, 2009.

D. Philippe, Mise à disposition d'une information personnalisée destinée aux patients traités par chimiothérapie au centre hospitalier de Bar-le-Duc, Thèse de doctorat en pharmacie. Faculté de Pharmacie. Nancy. Université Henri Poincaré - Nancy 1, 2011.

F. Pillon and . Les-corticoïdes, Actualités pharmaceutiques, pp.14-21, 2011.

M. Pires, A. Ilea, E. Bourel, V. Bellavoine, P. Berquin et al., Utilisation du r??gime c??tog??ne en troisi??me ligne dans les spasmes infantiles, Archives de P??diatrie, vol.20, issue.4, 2013.
DOI : 10.1016/j.arcped.2013.01.040

A. Pospiech, B. Yemnga, and M. De-kock, Prise en charge des nausées et des vomissements postopératoires : une priorité, pp.77-85, 2014.

J. Roger, M. Bureau, C. H. Dravet, P. Genton, and C. A. Tassinari, Les syndromes épileptiques de l'enfant et de l'adolescent, 2010.

F. Roila, M. Tonato, C. Basurto, M. Bella, R. Passalacqua et al., Antiemetic activity of high doses of metoclopramide combined with methylprednisolone versus metoclopramide alone in cisplatin-treated cancer patients: a randomized double-blind trial of the Italian Oncology Group for Clinical Research., Journal of Clinical Oncology, vol.5, issue.1, pp.141-149, 1987.
DOI : 10.1200/JCO.1987.5.1.141

F. Roila, D. Donati, S. Tamberi, and G. Margutti, Delayed emesis: incidence, pattern, prognostic factors and optimal treatment. Support. Care Cancer, pp.88-95, 2014.
DOI : 10.1007/s005200100295

F. Roila, J. Herrstedt, M. Aapro, R. J. Gralla, L. H. Einhorn et al., Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference, Annals of Oncology, vol.23, issue.3, pp.232-243, 2010.
DOI : 10.1185/030079907X167525

C. Rojas and B. S. Slusher, Pharmacological mechanisms of 5-HT3 and tachykinin NK1 receptor antagonism to prevent chemotherapy-induced nausea and vomiting, European Journal of Pharmacology, vol.684, issue.1-3, pp.1-3
DOI : 10.1016/j.ejphar.2012.01.046

L. Romundstad, H. Breivik, and A. Stubhaug, Les corticoïdes diminuent-ils la douleur et les nausées?vomissements postopératoires ? Le praticien en anesthésie reanimation, pp.154-157, 2008.

J. A. Roscoe, C. E. Heckler, G. R. Morrow, S. G. Mohile, S. R. Dakhil et al., Prevention of Delayed Nausea: A University of Rochester Cancer Center Community Clinical Oncology Program Study of Patients Receiving Chemotherapy, Journal of Clinical Oncology, vol.30, issue.27
DOI : 10.1200/JCO.2011.39.8123

R. Rupprecht, Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties, Psychoneuroendocrinology, vol.28, issue.2, pp.139-168, 2003.
DOI : 10.1016/S0306-4530(02)00064-1

A. Saint-martin and M. Burger, Le régime cétogène : un régime de l'extrême ? Médecine des maladies Métaboliques, pp.139-143, 2013.

K. Shaw and M. Zhang, Ganaxolone formulations and methods for the making and use thereof, 2011.

X. Shi, L. Zou, G. Yang, and Y. Ding, Prenatal stress exposure hypothesis for infantile spasms, Medical Hypotheses, vol.78, issue.6, pp.735-737, 2012.
DOI : 10.1016/j.mehy.2012.02.020

W. Shields, Infantile Spasms: Little Seizures, BIG Consequences, Epilepsy Currents, vol.6, issue.3, pp.63-69, 2006.
DOI : 10.1111/j.1535-7511.2006.00100.x

URL : http://europepmc.org/articles/pmc1464162?pdf=render

W. Sneader, Chapitre 16 Adrenal Cortex Hormones, Drug Discovery, pp.179-185, 2005.

C. E. Stafstrom, Animal Models of Infantile Spasms: Is the Holy Grail Finally in Sight? Epilepsy Curr, pp.131-133, 2008.

E. Suna, E. Pinar, and V. Sadi, Comparaison of granisetron plus dexamethasone versus an antiemetic cocktail containing midazolam and diphenhydramine for chemotherapy induced nausea and vomiting in children, Indian Journal of Medical and Paediatric Oncology, vol.34, issue.4, pp.270-273, 2013.

T. Suzuki, M. Sugimoto, H. Koyama, T. Mashimo, and I. Uchida, Inhibitory Effect of Glucocorticoids on Human-cloned 5-hydroxytryptamine3A Receptor Expressed in Xenopus Oocytes, Anesthesiology, vol.101, issue.3, pp.660-665, 2004.
DOI : 10.1097/00000542-200409000-00014

S. Tanihata, S. Oda, S. Nakai, and T. Uchiyama, Antiemetic effect of dexamethasone on cisplatin-induced early and delayed emesis in the pigeon, European Journal of Pharmacology, vol.484, issue.2-3, pp.2-3, 2004.
DOI : 10.1016/j.ejphar.2003.11.033

J. Vardy, K. S. Chiew, J. Galica, G. R. Pond, and I. Tannock, Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy, Br. J. Cancer, issue.7, pp.94-1011, 2006.

G. Vexiau, Spasmes Infantiles : Comparaison de deux cohortes rétrospectives prises en charge à 40 ans d'intervalle à Nancy, Thèse de doctorat en médecine, 2013.

V. Vidal, Issy-les-Moulineaux: Vidal, pp.1883-1884, 2010.

D. Ville, Traitements médicamenteux dans l'épilepsie de l'enfant. Service de Neuropédiatrie, Hôpital Femme Mère Enfant, p.503, 2015.

D. Ville, C. Chiron, J. Laschet, and O. Dulac, The ketogenic diet can be used successfully in combination with corticosteroids for epileptic encephalopathies, Epilepsy & Behavior, vol.48, pp.48-61, 2015.
DOI : 10.1016/j.yebeh.2015.03.003

J. Wang, J. Wang, Y. Zhang, G. Yang, A. Shang et al., Proteomic analysis on infantile spasm and prenatal stress, Epilepsy Research, vol.108, issue.7, pp.1174-1183
DOI : 10.1016/j.eplepsyres.2014.06.001

Y. Wang, Y. Zhang, X. Liang, G. Yang, and L. Zou, Effects of adrenal dysfunction and high-dose adrenocorticotropic hormone on NMDA-induced spasm seizures in young Wistar rats, Epilepsy Research, vol.100, issue.1-2, pp.100-125
DOI : 10.1016/j.eplepsyres.2012.02.001

J. Wanigasinghe, C. Arambepola, S. Sri-ranganathan, S. Sumanasena, and G. Attanapola, Randomized, Single-Blind, Parallel Clinical Trial on Efficacy of??Oral Prednisolone Versus Intramuscular Corticotropin on Immediate and Continued Spasm Control in West Syndrome, Pediatric Neurology, vol.53, issue.3, 2015.
DOI : 10.1016/j.pediatrneurol.2015.05.004

W. West, Peculiar Infantile Convulsions. The Lancet. 1841, pp.724-725

G. Yang, L. Zou, J. Wang, and Y. Ding, Epigenetic regulation of glucocorticoid receptor and infantile spasms, Medical Hypotheses, vol.76, issue.2, pp.187-189, 2011.
DOI : 10.1016/j.mehy.2010.09.014

. Thériaque, . Monographie, and ®. Solupred, Banque de données sur tous les médicaments disponibles en France. Centre National Hospitalier d'Information sur le Médicament, Disponible sur, p.7, 2015.